Recurrent nosebleeds are a common occurrence in childhood and adolescence. These are frequently treated by cautery and rarely give rise to further concern. The frequency with which nosebleeds present can lull clinicians into a false sense of security, so that serious underlying pathology may not be considered. Recurrent epistaxis is the first symptom in 90% of cases of hereditary haemorrhagic telangiectasial, which is associated with significant morbidity and mortality. We report a case of arm weakness in a young man with a history of recurrent epistaxes in whom hereditary haemorrhagic telangiectasia was subsequently diagnosed.
Recurrent nosebleeds are a common occurrence in childhood and adolescence. These are frequently treated by cautery and rarely give rise to further concern. The frequency with which nosebleeds present can lull clinicians into a false sense of security, so that serious underlying pathology may not be considered. Recurrent epistaxis is the first symptom in 90% of cases of hereditary haemorrhagic telangiectasial, which is associated with significant morbidity and mortality. We report a case of arm weakness in a young man with a history of recurrent epistaxes in whom hereditary haemorrhagic telangiectasia was subsequently diagnosed.
CASE HISTORY
A 36-year-old man was referred to us for further investigation after admission to another hospital following sudden onset of weakness in his right arm. The paralysis was complete, and there were no associated symptoms or prodrome. Within 2 h he had regained some finger movement, and in 2 days he was able to lift his arm off the bed. He remained well throughout this episode. There were no signs of cranial nerve deficit. By the time he came under our care a month later, he felt that he had residual impairment of higher order functions of his right hand such as handwriting, but neurological testing was entirely normal. He had perioral, palatal and periungual telangiectasia, not previously documented.
Initial investigations at presentation revealed a coin lesion on his chest X-ray in the right lower zone. Further chest X-rays and tomograms suggested that this might represent an arteriovenous malformation (AVM) confirmed by subsequent chest computerized tomography [CT( Figure   1 )]. CT brain scan revealed a haemorrhage in the left parietal region.
In the past he had suffered recurrent nosebleeds throughout adolescence and adulthood, treated on several occasions by cautery. He also described a spontaneous haemorrhage from under his left upper eyelid which had been self limiting. He had suffered from severe asthma in showing large arteriovenous malformation in the lower lobe of the right lung childhood which had required several hospital admissions, but this had been well controlled in the previous 10 years. On further questioning, he revealed that there was a strong family history of recurrent epistaxes ( Figure 2 ), and one of his paternal grand uncles had died from an uncontrolled nosebleed. Furthermore, one of the patient's young sons had had several episodes of nosebleeds. The patient's father had died at the age of 59 years following a cerebrovascular accident complicated by meningitis and intracranial abscess caused by Streptococcus milleri. He, too, had had a history of recurrent epistaxes and perioral skin lesions.
We requested a magnetic resonance imaging (MRI) scan of this patient's brain and spinal cord. A solitary lesion consistent with a subacute haemorrhage was found high in the left parietal region, associated with a small underlying vascular malformation. A second small vascular malformation was also located posterior to the lateral recess of the fourth ventricle on the left. He underwent a four-vessel cerebral angiogram. Injection of the left carotid artery confirmed the presence of a vascular malformation in the anterior parietal region on the left. This was fed by a solitary cerebral artery, and appeared to be predominantly a (Figure 3a ). On injection of the vertebrobasilar system, a second small vascular lesion was confirmed just posterior to the lateral recess of the fourth ventricle on the left, fed by the posterior inferior cerebellar artery (Figure 3b ). The patient has undergone successful coil embolization of the pulmonary arteriovenous malformation and stereotactic radiosurgery to both the intracranial arteriovenous malformations. When we last communicated with him, he reported that he was well and had not suffered any further respiratory or neurological episodes.
DISCUSSION
This patient had the stigmata of hereditary haemorrhagic telangiectasia and had suffered well-recognized complications of this disease. The diagnosis was supported by the positive family history of recurrent epistaxes transmitted through the generations in an autosomal dominant fashion.
Hereditary haemorrhagic telangiectasia (HHT) is a term coined by Hanes in 19092. It is an autosomal dominant disorder characterized by recurrent epistaxes and mucocutaneous telangiectases. It had previously been described by others, and hence is also known eponymously as the Osler-Weber-Rendu syndrome3-6. Most authors suggest that, to make the diagnosis confidently, two of the following features should be present: a positive family history, mucocutaneous telangiectases and epistaxes. Formerly, HHT was thought to be a rare disease, but recent studies have suggested its prevalence to be in the order of 1:390001 to 1:83007. The endoglin gene on chromosome 9q3 is the HHT gene in some pedigrees8. One further potential candidate gene is likewise located on chromosome 9q39, and a third maps to chromosome 12q10.
The case of HHT presented here illustrates the potentially serious morbidity and mortality that can befall people affected by this disease. In 1992, Porteous et al.1 published a clinical analysis of 98 patients with HHT, presenting the salient clinical features of this disease. Epistaxes are the first presenting feature in 90%, and originate from telangiectases over the nasal septum and inferior turbinates, beginning in puberty. Cutaneous telangiectases appeared between 5 to 20 years after the first nosebleed, and became more numerous with age. Common sites were the palms, nailbeds, lips, tongue and face. 25% had visible pulmonary AVMs on chest X-ray, commonly in the lower lobes. These were clinically important, predisposing to embolic phenomena, cerebral infarction and abscesses. Cerebral involvement was largely the consequence of pulmonary AVMs; however, 3% were found to have cerebral AVMs.
In 1988, White et a]. " published the largest North American series, 76 patients with pulmonary AVMs. A staggering 88% of these were found to have HHT as the underlying diagnosis. They showed that pulmonary AVMs per se were associated with significant morbidity including high output cardiac failure and a syndrome clinicallv similar to cyanotic heart disease. In addition, screening CT brain scans performed on these patients revealed that 36% had low attenuation lesions consistent with cerebral infarctions; 9% had a history of cerebral abscesses. Most intracranial morbidity in HHT is directly related to the presence of pulmonary AVMs and the predisposition to paradoxical and septic emboli. White et a]. suggest that patients with HHT should be screened for these by lateral and postero-anterior chest X-ray, and the measurement of standing and lying arterial oxygen saturations, hypoxaemia being more severe in the erect position (orthodeoxia) in the presence of pulmonary AVMs. Pulmonary angiography should be performed if these screening investigations are suggested. The patient's father bore the stigmata of HHT. He had probably suffered a fatal septic embolus secondary to an unrecognized underlying pulmonary AVM.
Hereditary haemorrhagic telangiectasia is far from being simply an oddity exhibited in medical examinations. A family history and stigmata of this disease can be quickly looked for in adolescents presenting with recurrent epistaxes. If HHT is suspected, pulmonary AVMs should be sought for and treated in expert centres. The management of asymptomatic cerebral AVMs is controversial. A strong case for screening affected individuals for cerebral AVMs with MRI has been made12. It has also been suggested that low-grade asymptomatic cerebral AVMs in younger individuals should be surgically extirpated13.
Family members at risk should be screened and the clinical geneticist has an important role to play if adequate screening is to be offered to those at risk.
